key: cord-0982350-lvsfmpe4
authors: Kim, Ye Kyung; Choi, Youn Young; Lee, Hyunju; Song, Eun Song; Ahn, Jong Gyun; Park, Su Eun; Lee, Taekjin; Cho, Hye-Kyung; Lee, Jina; Kim, Yae-Jean; Jo, Dae Sun; Kang, Hyun Mi; Lee, Joon Kee; Kim, Chun Soo; Kim, Dong Hyun; Kim, Hwang Min; Choi, Jae Hong; Eun, Byung Wook; Kim, Nam Hee; Cho, Eun Young; Kim, Yun-Kyung; Oh, Chi Eun; Kim, Kyung-Hyo; Choi, Eun Hwa
title: Differential Impact of Nonpharmaceutical Interventions on the Epidemiology of Invasive Bacterial Infections in Children During the Coronavirus Disease 2019 Pandemic
date: 2021-11-30
journal: Pediatr Infect Dis J
DOI: 10.1097/inf.0000000000003414
sha: b62264455bf7ccda247b089277b6d0f6558324b6
doc_id: 982350
cord_uid: lvsfmpe4

BACKGROUND: Invasive bacterial infection (IBI) remains a major burden of mortality and morbidity in children. As coronavirus disease 2019 (COVID-19) emerged, stringent nonpharmaceutical interventions (NPIs) were applied worldwide. This study aimed to evaluate the impact of NPIs on pediatric IBI in Korea. METHODS: From January 2018 to December 2020, surveillance for pediatric IBIs caused by 9 pathogens (S. pneumoniae, H. influenzae, N. meningitidis, S. agalactiae, S. pyogenes, S. aureus, Salmonella species, L. monocytogenes and E. coli) was performed at 22 hospitals throughout Korea. Annual incidence rates were compared before and after the COVID-19 pandemic. RESULTS: A total of 651 cases were identified and the annual incidence was 194.0 cases per 100,000 in-patients in 2018, 170.0 in 2019 and 172.4 in 2020. Most common pathogen by age group was S. agalactiae in infants < 3 months (n = 129, 46.7%), S. aureus in 3 to < 24 months (n = 35, 37.2%), Salmonella spp. in 24 to < 60 months (n = 24, 34.8%) and S. aureus in children ≥ 5 years (n = 128, 60.7%). Compared with 2018 to 2019, the incidence rate in 2020 decreased by 57% for invasive pneumococcal disease (26.6 vs. 11.5 per 100,000 in-patients, P = 0.014) and 59% for Salmonella spp. infection (22.8 vs. 9.4 per 100,000 in-patients, P = 0.018). In contrast, no significant changes were observed in invasive infections due to S. aureus, S. agalactiae and E. coli. CONCLUSIONS: The NPIs implemented during the COVID-19 pandemic reduced invasive diseases caused by S. pneumoniae and Salmonella spp. but not S. aureus, S. agalactiae and E. coli in children.

I nvasive bacterial infections (IBIs) are major causes of morbidity and mortality in children. Tracking epidemiologic changes of serious IBIs is important for developing strategies to decrease the disease burden and proper management. Accordingly, multicenter, hospital-based surveillance systems for IBIs in Korean children have been maintained since 1996. 1, 2 The surveillance system can be used as an important tool to assess changes in epidemiology of IBIs during the coronavirus disease 2019 .

After the first COVID-19 case was diagnosed in January 2020 in South Korea, a subsequent regional, however, large-scale outbreak occurred in February 2020, which prompted the health authorities to implement rigorous public health measures from March of 2020. 3, 4 Following implementation of nonpharmaceutical interventions (NPIs) in attempt to control the COVID-19, a reduction in various infectious diseases, including influenza, other respiratory viruses and vaccine-preventable diseases, has also been seen in South Korea. [5] [6] [7] Reports from other countries have also shown marked decline in acute respiratory viral infections including influenza and respiratory syncytial virus. 8, 9 Recent global studies found a significant reduction of IBIs due to S. pneumoniae, H. influenzae and N. meningitidis following the introduction of national COVID-19 containment in many

IBI was defined as the isolation of bacterial organisms from a normally sterile site by using culture, antigen detection or polymerase chain reaction. IBIs caused by nine bacterial organisms were collected; S. pneumoniae, H. influenzae, N. meningitidis, S. agalactiae, S. pyogenes, S. aureus, Salmonella species, L. monocytogenes and E. coli. Infants over 37 weeks of gestation to adolescents under 19 years of age were included. We excluded E. coli infections in children > 3 months of age to mainly collect community acquired infection rather than repetitive infections due to urogenital anomalies or immunocompromised status. S. aureus infection in those with central catheters or immunocompromised conditions was also excluded. Cases reported for invasive bacteria were retrospectively obtained on the annual basis (from January to December each year) for 3 years. All investigators submitted case information using a standard case report form that included age, sex, underlying medical conditions, isolated organism and date of isolation.

The distribution of bacterial organisms was analyzed according to age and time. Age groups were stratified as follows: < 3 months of age, 3 to 23 months of age, 24 to 59 months of age, and ≥ 5 years of age. Pearson's χ 2 was used to test annual difference of the proportion of age group and etiologic agents. The weekly number of cases for each IBI was assessed in 2020 versus 2018 to 2019. The annual incidence of IBIs except S. agalactiae and E. coli were calculated as the number of 100,000 new in-patients in the corresponding year. The annual incidence of IBIs due to S. agalactiae and E. coli were calculated per 10,000 newborns. The difference in annual cumulative incidences of IBIs by organism was compared by using a Poisson test. We performed statistical analyses using R version 4.0.5, and P value < 0.05 was considered statistically significant. Among these, 651 cases with IBIs were identified in the participating hospitals; 261 cases in 2018, 225 in 2019 and 165 in 2020, respectively (Table 1) . Overall, S. aureus was the most frequent cause of IBIs (n = 206, 31.6%), followed by S. agalactiae (n = 139, 21.4%), E. coli (n = 117, 18.0%), S. pneumoniae (n = 82, 12.6%) and Salmonella spp. (n = 70, 10.8%). There were few cases of S. pyogenes (n = 18, 2.8%) and H. influenzae (n = 15, 2.3%). In 2018 to 2019, more than 10% of IBIs were attributed to S. pneumoniae (13.0% in 2018 and 16.4% in 2019) and Salmonella spp. (13.8% in 2018 and 11.1% in 2019); however, only 6.7% and 5.5% were caused by S. pneumoniae and Salmonella spp. in 2020. Meanwhile, the proportion of S. aureus, S. agalactiae and E. coli infection did not show significant differences during the study period. The number of IBIs caused by S. pyogenes and H. influenzae in 

S. agalactiae was most predominant in infants younger than 3 months of age (n = 129, 46.7%), S. aureus in 3 to <24 months of age (n = 35, 37.2%), Salmonella spp. in 24 to <60 months of age (n = 24, 34.8%), S. aureus in children ≥ 5 years of age (n = 128, 60.7%) (Fig. 1 ). During the 3 years, the frequency of IBIs was highest in the infants under 3 months of age group (42.5%), followed by 32.5% in 5 to 18 years old, 14.5% in 3 to 23 months old and 10.6% in 24 to 59 months old. The age proportion of IBIs changed during the study period (Fig. 2) . In 2020, the proportion of IBIs in infants younger than 3 months of age was significantly greater than in the previous 2 years (38.7% in 2018 and 40.2% 2019 vs. 51.5% in 2020, P = 0.008) and the proportion of children 5 to 18 years of age tended to decrease (32.2% in 2018 and 37.1% in 2019 vs. 26.7% in 2020, P = 0.084).

The etiologic organisms of IBIs differed according to the age group ( Fig. 1 ). S. agalactiae (129/276, 46.7%) and E. coli (116/276, 42.0%) were responsible for the majority of IBIs in infants < 3 months of age. In children 3 months of age or older, S. aureus was the leading pathogen (47.9%, 179/374) followed by S. pneumoniae 

The annual trend in the number of weekly count for IBIs by each organism was shown in Fig. 3A . There were significant reductions in the cumulative cases of S. pneumoniae and Salmonella spp. in 2020 compared with 2018 to 2019. The cumulative case number of S. pneumoniae was similar to that of the previous 2 years until March 2020, while thereafter, the case number did not rise. A sharp rising pattern in late autumn and early winter detected in 2018 to 2019 was not seen in 2020. Among Salmonella spp. infection, 21 and 17 cases were detected from June to September in 2018 and 2019, respectively, while 6 cases were identified during the same period in 2020. In contrast, the cumulative curve patterns of S. agalactiae, S. aureus and E. coli were similar throughout the study period. Figure 3B showed the annual incidence of IBIs by each organism from 2018 to 2020. Consistent with the results of the cumulative weekly count, a substantial reduction in the incidence of S. pneumoniae and Salmonella spp. infection in 2020 was observed, compared with 2018 to 2019.

In 2020, there was a 57% reduction in the incidence rate of invasive pneumococcal disease compared with that of 2018 to 2019 (26.6 per 100,000 in-patients in 2018-2019 vs. 11.5 per 100,000 in-patients in 2020, rate ratio of 0.43; 95% confidence interval, 0.22-0.86; P = 0.014, Table 2 ). Likewise, the incidence rate of invasive disease due to Salmonella spp. in 2020 showed 59% decrease compared with the average incidence over the past 2 years (22.8 per 100,000 in-patients in 2018-2019 vs. 9.4 per 100,000 inpatients in 2020, rate ratio of 0.41; 95% confidence interval, 0.19-0.88; P = 0.018, Table 2 ). The cumulative incidences of S. aureus, S. agalactiae and E. coli infection did not change significantly over 3 years (Table 2 ). 

In this nationwide multicenter retrospective study, we demonstrated a significant reduction in invasive bacterial disease due to S. pneumoniae and Salmonella spp. during the COVID-19 outbreak, in comparison with the previous 2 years of 2018 to 2019. However, there was no significant difference in the incidence of invasive disease due to S. aureus, S. agalactiae and E. coli during the same period.

Most noteworthy was the observation that IBIs caused by S. pneumoniae and Salmonella spp. markedly decreased. Although there was no statistical significance due to the small number, S. pyogenes and H. influenzae also declined. The most possible explanation for the differential impact of COVID-19 NPIs on the epidemiology of pediatric IBIs is the difference in the transmission route by organism. S. pneumoniae, S. pyogenes and H. influenzae reside in the respiratory tracts and are mainly transmitted person-to-person through the inhalation of respiratory droplets or close contact. 14, 15 Day care attendance and crowding are well-known risk factors for invasive pneumococcal disease in children by facilitating the person-to-person transmission and nasopharyngeal carriage. 16, 17 It is likely that school closure, avoiding attendance to daycare center, mandatory use of facial masks and enhanced personal hygiene applied during the COVID-19 pandemic led to substantial decrease in pneumococcal transmission. Studies from England described the association of reduction in invasive pneumococcal disease with lockdown during the COVID-19 pandemic. 18, 19 A report from a single center found significant declines in 2020 compared with 2018 to 2019 in invasive infections due to S. pyogenes and S. pneumoniae but not S. aureus. 20 Brueggemann et al 10 reported worldwide reduction in invasive disease caused by S. pneumoniae and H. influenzae in early 2020 along with the implementation of public large-scale containment measures.

Another remarkable finding was a reduction in the incidence of Salmonella spp. infection in 2020. Salmonella infection is a food-borne illness and it peaks during the summer months on north hemisphere, which is probably associated with rapid replication in warm temperature and frequent eating out in summer. 21 Approximately 95% of salmonellosis in humans occurs through contaminated food, in particular, eggs, raw meat, dairy products and fresh vegetables. 22 International travel is also a major source in Salmonella infection, comprising 4% to 9% of traveler's diarrhea. 23 In a study for imported infectious diseases in South Korea, salmonellosis was associated with international travel during summer season, and imported cases comprised of 15.3% of salmonellosis with increasing trend. 24 Hand hygiene procedures are already known as an effective tool to lower the incidence of Salmonella infection. 25 The mandatory 14-day quarantine policy for all overseas travelers introduced from April 2020 in South Korea and worldwide lockdown led to decrease in domestic and international travel. Enhanced public hygiene and food handling processes, changes in eating behavior and decreased international travel may have contributed to a reduction in Salmonella infection.

Additional plausible explanation for decrease in IBIs may be related to decrease in various respiratory viral infections affected by NPIs. Secondary bacterial infections are commonly seen after respiratory infection. 26 Respiratory viral infections have an effect on mucosal/epithelial barrier, immunologic dysregulation and microbiota residing on both respiratory and gastrointestinal tract, which might increase a susceptibility to secondary bacterial infections. 27, 28 During the COVID-19 pandemic, a remarkable reduction in respiratory viral infections have been reported in many countries including South Korea. 29, 30 Decline in viral respiratory tract infections may have affected a decrease in pneumococcal infection. However, a decline in Salmonella spp. infection, a non-respiratory pathogen, is more likely a direct result of NPIs itself through reinforcement of personal hygiene and interruption of movement and person-to-person contact.

Meanwhile, there was no significant difference in the incidences of S. agalactiae and E. coli over the 3 years. In line with earlier studies, 1,2 S. agalactiae and E. coli remained main contributors to IBIs of the infants group. Since S. agalactiae and E. coli are usually acquired and colonizes during the perinatal period, it is assumed that these organisms were minimally affected by NPIs in 2020. 31 This implicates S. agalactiae and E. coli are unlikely to be preventable by NPIs, especially in neonates and young infants. S. aureus remained the leading cause of pediatric IBI without a significant difference in incidence throughout the study period, especially in children ≥ 5 years of age. This may be due to the fact that S. aureus is a human commensal residing on the skin and anterior nares. 32 In this study, an increase in the proportion of cases under 3 months of age was observed in concordance with the reduction of cases among preschool and school-age children in 2020. Taking into consideration of the major pathogens of this age group (S. agalactiae and E. coli) and route of acquisition of these pathogens this may be explained. The relative increase in proportion of infants under 3 months of age is also related to the decrease of infections in older children, who were more physically and socially active before COVID-19. Low adherence to personal hygiene and limitations in mask use might have a role in the preserved proportion of children under 5 years old.

There are several limitations in our study. First, the decline of IBI cases might result from reduced healthcare-seeking behaviors during the COVID-19 pandemic. To avoid the underestimation of IBI, we calculated the incidence with annual number of pediatric admission and birth number. Since most of IBIs manifest with a fever and lethargic feature, it is less likely to be missed. In fact, the number of infections caused by S. agalactiae and E. coli in young infants did not decrease, demonstrating that this surveillance system had not been disrupted by the COVID-19. Second, it is not possible to determine whether the decrease in IBIs is the result of reduced bacterial transmission and acquisition or the reduction in various viral respiratory tract infections. Changes in antibiotic prescriptions can have affected the epidemiology of IBIs. 33 Lastly, serotypes were not determined for H. influenzae and S. pneumoniae in this surveillance.

Despite these limitations, through comparison of incidence rate of IBIs due to nine bacterial pathogens before and after stringent implementation of various NPIs, we found distinct differences in changes in epidemiology according to pathogen and different age groups in children. These findings give insights into factors associated with the development of IBIs in children.

In summary, among 9 major pathogens of IBIs in children, the incidences of S. pneumoniae and Salmonella spp. decreased significantly in 2020, when NPIs came into effect, compared with in 2018 and 2019. This finding suggests that public health measures may attribute to prevention of some IBIs in the pediatric population. 

Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter study

Etiology of invasive bacterial infections in immunocompetent children in Korea (2006-2010): a retrospective multicenter study

The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures

Effect of nonpharmaceutical interventions on transmission of severe acute respiratory syndrome coronavirus 2, South Korea

Impact of public health interventions on seasonal influenza activity during the COVID-19 outbreak in Korea

Impact of social distancing on incidence of vaccine-preventable diseases, South Korea

Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study

Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter

NPIsImpactOnFlu Consortium. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

Social distancing for COVID-19 and diagnoses of other infectious diseases in children

COVID-19 and the law of unforeseen consequences

High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study

An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children

Risk factors for carriage of Streptococcus pneumoniae in children

Risk factors for primary invasive pneumococcal disease among children in Finland

Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study

Invasive meningococcal disease, 2011-2020, and impact of the COVID-19 pandemic

The indirect impact of the SARS-CoV-2 pandemic on invasive group a Streptococcus, Streptococcus pneumoniae and Staphylococcus aureus infections in Houston area children

Effects of climate change on Salmonella infections

Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network

Global etiology of travelers' diarrhea: systematic review from 1973 to the present

Importation of travel-related infectious diseases is increasing in South Korea: an analysis of salmonellosis, shigellosis, malaria, and dengue surveillance data

The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including handwashing and alcohol-based hand sanitizers

Bacterial coinfection in influenza: a grand rounds review

Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia

Respiratory viral infection predisposing for bacterial disease: a concise review

Trends in viral respiratory infections during COVID-19 pandemic

Trends in respiratory virus infections during the COVID-19 pandemic in Singapore

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

The role of nasal carriage in Staphylococcus aureus infections

Decreased use of broad-spectrum antibiotics during COVID-19 epidemic in South Korea